Insights

The VALUE trial found that amlodipine, a calcium channel blocker, was associated with fewer heart attacks and strokes compared to valsartan, an angiotensin receptor blocker. Blood pressure control was the key factor in patient outcomes.

Area of Science:

  • Cardiology
  • Pharmacology
  • Hypertension Research

Background:

  • The Valsartan Antihypertensive Long-Term Use Evaluation (VALUE) Trial investigated two antihypertensive strategies: valsartan (angiotensin receptor blocker) versus amlodipine (calcium channel blocker).
  • Diuretics were added as needed to achieve blood pressure goals in over 15,000 patients over 4.2 years.
  • The study aimed to compare coronary heart disease outcomes between the two treatment groups.

Discussion:

  • While the primary composite endpoint for cardiac morbidity and mortality showed no significant difference, amlodipine demonstrated a statistically significant reduction in myocardial infarction and a trend towards reduced stroke events compared to valsartan.
  • A non-significant increase in hospitalised heart failure was observed with amlodipine.
  • Early achievement of lower blood pressure levels in the amlodipine group likely contributed to its observed benefits.

Key Insights:

  • Lowering blood pressure is the primary determinant of outcomes in antihypertensive therapy trials.
  • Valsartan treatment was associated with a lower incidence of new-onset diabetes compared to amlodipine.
  • Amlodipine showed a potential benefit in reducing cardiovascular events like myocardial infarction and stroke.

Outlook:

  • Further research could explore the long-term impact of these antihypertensive strategies on specific cardiovascular endpoints and diabetes incidence.
  • The findings underscore the importance of individualized treatment approaches in hypertension management.
  • Future trials may focus on optimizing combination therapies to maximize benefits and minimize risks.

Related Concept Videos

Critical Values01:31

Critical Values

A critical value is a definite value obtained from a particular probability distribution at a predecided confidence level (or a predecided significance level) for a given population parameter. The critical value provides demarcation that separates the sample statistics that are likely to occur from the ones that are unlikely to occur based on the given probability distribution and the population parameter to be estimated. The critical value for normal distribution is obtained from the z...
P-value01:10

P-value

P-value is one of the most crucial concepts in statistics.
P-value stands for the probability value.  P-value is the probability that, if the null hypothesis is true, the results from another randomly selected sample will be as extreme or more extreme as the results obtained from the given sample.
A large P-value calculated from the data indicates to  not reject the null hypothesis. But a higher P-value does not mean that the null hypothesis is true. The smaller the P-value, the more unlikely...
Decision Making: P-value Method01:09

Decision Making: P-value Method

The process of hypothesis testing based on the P-value method includes calculating the P- value using the sample data and interpreting it.
First, a specific claim about the population parameter is proposed. The claim is based on the research question and is stated in a simple form. Further, an opposing statement to the claim  is also stated. These statements can act as null and alternative hypotheses:  a null hypothesis would be a neutral statement while the alternative hypothesis can have a...
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Trial and Error and Algorithm01:12

Trial and Error and Algorithm

A problem-solving strategy is a plan of action used to find a solution. Different strategies have distinct action plans. Trial and error involves trying different solutions until one works. For instance, to fix a broken printer, you might check ink levels, ensure the paper tray isn't jammed, and verify the printer's connection to your laptop. This method can be time-consuming but is commonly used. Thomas Edison, for example, used trial and error to find a suitable filament for the light bulb,...